Sigilon TherapeuticsInc Valuation
| SGTXDelisted Stock | USD 22.47 0.00 0.00% |
At this time, the company appears to be overvalued. Sigilon TherapeuticsInc has a current Real Value of $15.28 per share. The regular price of the company is $22.47. Our model measures the value of Sigilon TherapeuticsInc from inspecting the company fundamentals such as Operating Margin of (1.75) %, return on equity of -0.76, and Shares Outstanding of 2.5 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Sigilon TherapeuticsInc's price fluctuation is very steady at this time. Calculation of the real value of Sigilon TherapeuticsInc is based on 3 months time horizon. Increasing Sigilon TherapeuticsInc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Sigilon TherapeuticsInc is useful when determining the fair value of the Sigilon stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Sigilon TherapeuticsInc. Since Sigilon TherapeuticsInc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sigilon Stock. However, Sigilon TherapeuticsInc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 22.47 | Real 15.28 | Hype 22.47 | Naive 28.07 |
The real value of Sigilon Stock, also known as its intrinsic value, is the underlying worth of Sigilon TherapeuticsInc Company, which is reflected in its stock price. It is based on Sigilon TherapeuticsInc's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Sigilon TherapeuticsInc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sigilon TherapeuticsInc's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sigilon TherapeuticsInc helps investors to forecast how Sigilon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sigilon TherapeuticsInc more accurately as focusing exclusively on Sigilon TherapeuticsInc's fundamentals will not take into account other important factors: Sigilon TherapeuticsInc Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Sigilon TherapeuticsInc's current stock value. Our valuation model uses many indicators to compare Sigilon TherapeuticsInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sigilon TherapeuticsInc competition to find correlations between indicators driving Sigilon TherapeuticsInc's intrinsic value. More Info.Sigilon TherapeuticsInc is rated below average in price to book category among related companies. It is rated below average in price to sales category among related companies fabricating about 3.46 of Price To Sales per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Sigilon TherapeuticsInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sigilon TherapeuticsInc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sigilon TherapeuticsInc's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sigilon TherapeuticsInc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sigilon TherapeuticsInc and how it compares across the competition.
About Sigilon TherapeuticsInc Valuation
The delisted stock valuation mechanism determines the current worth of Sigilon TherapeuticsInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Sigilon TherapeuticsInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Sigilon TherapeuticsInc based exclusively on its fundamental and basic technical indicators. By analyzing Sigilon TherapeuticsInc's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Sigilon TherapeuticsInc's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sigilon TherapeuticsInc. We calculate exposure to Sigilon TherapeuticsInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sigilon TherapeuticsInc's related companies.Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Sigilon Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Sigilon Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 66 people.
8 Steps to conduct Sigilon TherapeuticsInc's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sigilon TherapeuticsInc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sigilon TherapeuticsInc's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sigilon TherapeuticsInc's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sigilon TherapeuticsInc's revenue streams: Identify Sigilon TherapeuticsInc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sigilon TherapeuticsInc's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sigilon TherapeuticsInc's growth potential: Evaluate Sigilon TherapeuticsInc's management, business model, and growth potential.
- Determine Sigilon TherapeuticsInc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sigilon TherapeuticsInc's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Sigilon TherapeuticsInc Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Sigilon TherapeuticsInc does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 32.4 M | |
| Forward Price Earnings | 2.7655 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Sigilon Stock
If you are still planning to invest in Sigilon TherapeuticsInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sigilon TherapeuticsInc's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |